Clinical utility of folate pathway genetic polymorphisms in the diagnosis of autism spectrum disorders

Psychiatric Genetics

Volumn 26, Issue 6, 2016, Pages 281-286

  Mohammad, Naushad Shaik ^a,b,e   Sai Shruti, P ^e   Bharathi, Venkat ^e   Krishna Prasad, Chintakindi ^b   Hussain, Tajamul ^f   Alrokayan, Salman A ^g   Naik, Usha ^c   Radha Rama Devi, Akella ^a,d  

^a SANDOR LIFE SCIENCES PVT LTD   (India)

^b Center for DNA Fingerprinting and Diagnostics   (India)

^c Niloufer Institute of Child Health   (India)

^d Rainbow Children's Hospital   (India)

^e SASTRA UNIVERSITY   (India)

^f KING SAUD UNIVERSITY   (Saudi Arabia)

^g KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

autism spectrum disorders; folate pathway; genetic polymorphisms; homocysteine

Indexed keywords

5 METHYLTETRAHYDROFOLATE HOMOCYSTEINE METHYLTRANSFERASE; FOLIC ACID; GLUTAMATE CARBOXYPEPTIDASE II; GLYCINE HYDROXYMETHYLTRANSFERASE; HOMOCYSTEINE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MTHFR PROTEIN, HUMAN;

AMINO ACID BLOOD LEVEL; ARTICLE; ARTIFICIAL NEURAL NETWORK; AUTISM; CHILD; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEMALE; FUZZY LOGIC; GENE; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC VARIABILITY; HUMAN; HYPERHOMOCYSTEINEMIA; MALE; META ANALYSIS; MTHFR C677T GENE; PREDICTOR VARIABLE; PRIORITY JOURNAL; RISK ASSESSMENT; ALLELE; BLOOD; GENE FREQUENCY; GENETIC PREDISPOSITION; GENETIC SCREENING; GENETICS; GENOTYPE; METABOLISM; ODDS RATIO; PROCEDURES; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

ALLELES; AUTISM SPECTRUM DISORDER; AUTISTIC DISORDER; CHILD; FOLIC ACID; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENETIC TESTING; GENOTYPE; HOMOCYSTEINE; HUMANS; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS;

EID: 84991457485     PISSN: 09558829     EISSN: 14735873     Source Type: Journal    
DOI: 10.1097/YPG.0000000000000152     Document Type: Article

References (28)

1. Ali A, Waly MI, Al-Farsi YM, Essa MM, Al-Sharbati MM, Deth RC. (2011). Hyperhomocysteinemia among Omani autistic children: a case-control study. Acta Biochim Pol 58: 547-551
2. Al-Farsi YM, Waly MI, Deth RC, Al-Sharbati MM, Al-Shafaee M, Al-Farsi O, et al. (2013). Low folate and vitamin B12 nourishment is common in Omani children with newly diagnosed autism. Nutrition 29: 537-541
3. Arthi K, Tamilarasi A. (2008). Prediction of autistic disorder using neuro fuzzy system by applying ANN technique. Int J Dev Neurosci 26: 699-704
4. Berry RJ. (2013). Maternal prenatal folic acid supplementation is associated with a reduction in development of autistic disorder. J Pediatr 163: 303-304
5. Boris M, Goldblatt A, Galanko J, James SJ. (2004). Association of MTHFR gene variants with autism. J Am Phys Surg 9: 106-108
6. dos Santos PA, Longo D, Brandalize AP, Schüler-Faccini L. (2010). MTHFR C677T is not a risk factor for autism spectrum disorders in South Brazil. Psychiatr Genet 20: 187-189
7. Geier DA, Geier MR. (2006). A clinical and laboratory evaluation of methionine cycle-transsulfuration and androgen pathway markers in children with autistic disorders. Horm Res 66: 182-188
8. Guo T, Chen H, Liu B, Ji W, Yang C. (2012). Methylenetetrahydrofolate reductase polymorphisms C677T and risk of autism in the Chinese Han population. Genet Test Mol Biomarkers 16: 968-973
9. Han Y, Xi QQ, Dai W, Yang SH, Gao L, Su YY, Zhang X. (2015). Abnormal transsulfuration metabolism and reduced antioxidant capacity in Chinese children with autism spectrum disorders. Int J Dev Neurosci 46: 27-32
10. Hendren RL, James SJ, Widjaja F, Lawton B, Rosenblatt A, Bent S. (2016). Randomized, placebo-controlled trial of methyl B12 for children with autism. J Child Adolesc Psychopharmacol [Epub ahead of print
11. James SJ, Cutler P, Melnyk S, Jernigan S, Janak L, Gaylor DW, Neubrander JA. (2004). Metabolic biomarkers of increased oxidative stress and impaired methylation capacity in children with autism. Am J Clin Nutr 80: 1611-1617
12. James SJ, Melnyk S, Jernigan S, Cleves MA, Halsted CH, Wong DH, et al. (2006). Metabolic endophenotype and related genotypes are associated with oxidative stress in children with autism. Am J Med Genet B Neuropsychiatr Genet 141B: 947-956
13. James SJ, Melnyk S, Fuchs G, Reid T, Jernigan S, Pavliv O, et al. (2009). Efficacy of methylcobalamin and folinic acid treatment on glutathione redox status in children with autism. Am J Clin Nutr 89: 425-430
14. James SJ, Melnyk S, Jernigan S, Pavliv O, Trusty T, Lehman S, et al. (2010). A functional polymorphism in the reduced folate carrier gene and DNA hypomethylation in mothers of children with autism. Am J Med Genet B Neuropsychiatr Gene 153B: 1209-1220
15. Laraqui A, Allami A, Carrié A, Coiffard AS, Benkouka F, Benjouad A, et al. (2006). Influence of methionine synthase (A2756G) and methionine synthase reductase (A66G) polymorphisms on plasma homocysteine levels and relation to risk of coronary artery disease. Acta Cardiol 61: 51-61
16. Liu X, Solehdin F, Cohen IL, Gonzalez MG, Jenkins EC, Lewis ME, Holden JJ. (2011). Population-and family-based studies associate the MTHFR gene with idiopathic autism in simplex families. J Autism Dev Disord 41: 938-944
17. Mendes CC, Raimundo AM, Oliveira LD, Zampieri BL, Marucci GH, Biselli JM, et al. (2013). DHFR 19-bp deletion and SHMT C1420T polymorphisms and metabolite concentrations of the folate pathway in individuals with Down syndrome. Genet Test Mol Biomarkers 17: 274-277
18. Mohammad NS, Jain JM, Chintakindi KP, Singh RP, Naik U, Akella RR. (2009). Aberrations in folate metabolic pathway and altered susceptibility to autism. Psychiatr Genet 19: 171-176
19. Mohammad NS, Yedluri R, Addepalli P, Gottumukkala SR, Digumarti RR, Kutala VK. (2011). Aberrations in one-carbon metabolism induce oxidative DNA damage in sporadic breast cancer. Mol Cell Biochem 349 (1-2): 159-167
20. Naushad SM, Jain JM, Prasad CK, Naik U, Akella RR. (2013). Autistic children exhibit distinct plasma amino acid profile. Indian J Biochem Biophys 50: 474-478
21. Park J, Ro M, Pyun JA, Nam M, Bang HJ, Yang JW, et al. (2014). MTHFR 1298A>C is a risk factor for autism spectrum disorder in the Korean population. Psychiatry Res 2151: 258-259
22. Pasca SP, Nemes B, Vlase L, Gagyi CE, Dronca E, Miu AC, Dronca M. (2006). High levels of homocysteine and low serum paraoxonase 1 arylesterase activity in children with autism. Life Sci 78: 2244-2248
23. Pasca SP, Dronca E, Kaucsár T, Craciun EC, Endreffy E, Ferencz BK, et al. (2009). One carbon metabolism disturbances and the C677T MTHFR gene polymorphism in children with autism spectrum disorders. J Cell Mol Med 13: 4229-4238
24. Sener EF, Oztop DB, Ozkul Y. (2014). MTHFR gene C677T polymorphism in autism spectrum disorders. Genet Res Int 2014: 698574
25. Surén P, Roth C, Bresnahan M, Haugen M, Hornig M, Hirtz D, et al. (2013). Association between maternal use of folic acid supplements and risk of autism spectrum disorders in children. JAMA 309: 570-577
26. Wolthers KR, Scrutton NS. (2009). Cobalamin uptake and reactivation occurs through specific protein interactions in the methionine synthase-methionine synthase reductase complex. FEBS J 276: 1942-1951
27. Yamada K, Chen Z, Rozen R, Matthews RG. (2001). Effects of common polymorphisms on the properties of recombinant human methylenetetrahydrofolate reductase. Proc Natl Acad Sci USA 98: 14853-14858
28. Yeganeh F, Nikbakht F, Bahmanpour S, Rastegar K, Namavar R. (2013). Neuroprotective effects of NMDA and group I metabotropic glutamate receptor antagonists against neurodegeneration induced by homocysteine in rat hippocampus: in vivo study. J Mol Neurosci 50: 551-557